project id: TCGA-ESCA; case submitter id: TCGA-IG-A4QS; analyte type: DNA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.11; rna integrity number: 7.3; age at index: 71; days to birth: -26273; days to death: 118; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1941; age at diagnosis: 26273; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 8.0; icd 10 code: C15.9; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thoracic esophagus; synchronous malignancy: No; tissue or organ of origin: Thoracic esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 79; days to sample procurement: 0; initial weight: 930.0; portion submitter id: TCGA-IG-A4QS-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 92.0;